Endometrial stromal sarcomas and related high-grade sarcomas: Immunohistochemical and molecular genetic study of 31 cases

American Journal of Surgical Pathology

Volumn 32, Issue 8, 2008, Pages 1228-1238

  Kurihara, Shuichi ^a   Oda, Yoshinao ^a   Ohishi, Yoshihiro ^a   Iwasa, Atsuko ^a   Takahira, Tomonari ^a   Kaneki, Eisuke ^a   Kobayashi, Hiroaki ^a   Wake, Norio ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Endometrial stromal sarcoma; JAZF1 JJAZ1 gene fusion; P53; Undifferentiated endometrial sarcoma

Indexed keywords

BETA CATENIN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; CTNNB1 PROTEIN, HUMAN; JAZF1 PROTEIN, HUMAN; JJAZ1 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; FEMALE; FUSION GENE; GENE SEQUENCE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MISSENSE MUTATION; MOLECULAR GENETICS; PROTEIN EXPRESSION; TP53 GENE; TUMOR GENE; CANCER STAGING; CELL DIFFERENTIATION; CELL NUCLEUS; CHEMISTRY; COMPARATIVE STUDY; ENDOMETRIUM TUMOR; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; BETA CATENIN; CELL DIFFERENTIATION; CELL NUCLEUS; DNA MUTATIONAL ANALYSIS; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARCOMA, ENDOMETRIAL STROMAL; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 49249084749     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31816a3b42     Document Type: Article

References (26)

1. Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11:155-168.
2. Amant F, Woestenborghs H, Vandenbroucke V, et al. Transition of endometrial stromal sarcoma into high-grade sarcoma. Gynecol Oncol. 2006;103:1137-1140.
3. Balleine RL, Earls PJ, Webster LR, et al. Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma. Int J Gynecol Pathol. 2004;23:138-144.
4. Bhargava R, Shia J, Hummer AJ, et al. Distinction of endo-metrial stromal sarcomas from "hemangiopericytomatous"tumors using a panel of immunohistochemical stains. Mod Pathol. 2005;18:40-47.
5. Borden EC, Baker LH, Bell RS, et al. Soft tissue sarcomas of adults: state of the translational science. Clin Cancer Res. 2003;9: 1941-1956.
6. Chang KL, Crabtree GS, Lim-Tan SK, et al. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol. 1990;14:415-438.
7. Cheung AN, Ng WF, Chung LP, et al. Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation. J Clin Pathol. 1996;49:604-607.
8. Chu PG, Arber DA, Weiss LM, et al. Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol. 2001;14:465-471.
9. Harvey JM, Clark GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999;17:1474-1481.
10. Helman LJ, Meltzer P. Mechanisms of sarcoma development. Nat Rev Cancer. 2003;3:685-694.
11. Hendrickson MR, Tavassoli FA, Kempson RL, et al. Mesenchymal tumours and related lesions. In: Tavassoli FA, Devilee P, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press;2003:233-244.
12. Hrzenjak A, Tippl M, Kremser ML, et al. Inverse correlation of secreted frizzled-related protein 4 and beta-catenin expression in endometrial stromal sarcomas. J Pathol. 2004;204:19-27.
13. Hrzenjak A, Moinfar F, Tavassoli FA, et al. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase- polymerase chain reaction optimized for paraffin-embedded tissue. J Mol Diagn. 2005;7:388-395.
14. Huang HY, Ladanyi M, Soslow RA. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity. Am J Surg Pathol. 2004;28:224-232.
15. Ilyas M. Wnt signalling and the mechanistic basis of tumour development. J Pathol. 2005;205:130-144.
16. Koontz JI, Soreng AL, Nucci M, et al. Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors. Proc Natl Acad Sci USA. 2001;98:6348-6353.
17. Micci F, Walter CU, Teixeira MR, et al. Cytogenetic and molecular genetic analyses of endometrial stromal sarcoma: nonrandom involvement of chromosome arms 6p and 7p and confirmation of JAZF1/JJAZ1 gene fusion in t(7;17). Cancer Genet Cytogenet. 2003;144:119-124.
18. Montgomery E, Argani P, Hicks JL, et al. Telomere lengths of translocation-associated and nontranslocation-associated sarcomas differ dramatically. Am J Pathol. 2004;164:1523-1529.
19. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol. 2005;18:68-74.
20. Nucci MR, Harburger D, Koontz J, et al. Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol. 2007;31:65-70.
21. Oda Y, Sakamoto A, Satio T, et al. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma. Mod Pathol. 2000;13:994-1004.
22. Oliva E, Clement PB, Young RH. Endometrial stromal tumors: an update on a group of tumors with a protean phenotype. Adv Anat Pathol. 2000;7:257-281.
23. Oliva E, Leval L, Soslow RA, et al. High frequency of JAZF1-JJAZ1 gene fusion in endometrial stromal tumors with smooth muscle differentiation by interphase FISH detection. Am J Surg Pathol. 2007;31:1277-1284.
24. Reich O, Regauer S, Urdl W, et al. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer. 2000;82:1030-1034.
25. Silverberg SG, Kurman RJ. Endometrial stromal tumors. In: Silverberg SG, Kurman RJ, eds. Atlas of Tumor Pathology. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease. Third Series, Fascicle 3. Washington, DC: Armed Forces Institute of Pathology;1992:91-112.
26. Zhu XQ, Shi YF, Cheng XD, et al. Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma. Gynecol Oncol. 2004;92:71-79.